Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126678971 | 12667897 | 1 | I | 20160711 | 20160819 | 20160819 | EXP | DE-PFIZER INC-2016342094 | PFIZER | HAAS, S.. TYPE A AORTIC DISSECTION DURING LATE PREGNANCY IN A PATIENT WITH MARFAN SYNDROME. CANADIAN JOURNAL OF ANESTHESIA. 2011;58 (11):1024-1028 | 0.00 | Y | 0.00000 | 20160819 | MD | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126678971 | 12667897 | 1 | PS | PROPOFOL. | PROPOFOL | 1 | Transplacental | 200 MG, UNK | U | 77908 | 200 | MG | EMULSION FOR INJECTION | ||||||
| 126678971 | 12667897 | 2 | SS | ROCURONIUM BROMIDE. | ROCURONIUM BROMIDE | 1 | Transplacental | 100 MG, UNK | U | 78519 | 100 | MG | |||||||
| 126678971 | 12667897 | 3 | SS | MIDAZOLAM | MIDAZOLAMMIDAZOLAM HYDROCHLORIDE | 1 | Transplacental | 3 MG, UNK | U | 75293 | 3 | MG | |||||||
| 126678971 | 12667897 | 4 | SS | NOREPINEPHRINE | NOREPINEPHRINENOREPINEPHRINE BITARTRATE | 1 | Transplacental | 0.03 UG/KG/MIN | U | 0 | .03 | UG/KG | |||||||
| 126678971 | 12667897 | 5 | SS | NOREPINEPHRINE | NOREPINEPHRINENOREPINEPHRINE BITARTRATE | 1 | Transplacental | 0.1 UG/KG/MIN | U | 0 | .1 | UG/KG | |||||||
| 126678971 | 12667897 | 6 | SS | SUFENTANIL | SUFENTANIL | 1 | Transplacental | 60 UG, UNK | U | 0 | 60 | UG | |||||||
| 126678971 | 12667897 | 7 | SS | SUFENTANIL | SUFENTANIL | 1 | Transplacental | 0.7 UG/KG/MIN | U | 0 | .7 | UG/KG | |||||||
| 126678971 | 12667897 | 8 | SS | SEVOFLURANE. | SEVOFLURANE | 1 | 2.0% END-TIDAL IN 100% OXYGEN | U | 0 | ||||||||||
| 126678971 | 12667897 | 9 | SS | LIDOCAINE. | LIDOCAINE | 1 | Transplacental | 1% LIDOCAINE 0.5 ML | U | 0 | .5 | ML |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126678971 | 12667897 | 1 | General anaesthesia |
| 126678971 | 12667897 | 2 | General anaesthesia |
| 126678971 | 12667897 | 3 | Sedation |
| 126678971 | 12667897 | 4 | Hypotension |
| 126678971 | 12667897 | 6 | General anaesthesia |
| 126678971 | 12667897 | 8 | General anaesthesia |
| 126678971 | 12667897 | 9 | Infiltration anaesthesia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126678971 | 12667897 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126678971 | 12667897 | Maternal exposure during pregnancy | |
| 126678971 | 12667897 | Respiratory depression |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |